Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 02/18

Trade details

Type: Insider sale
Amount: $5,298,000
Shares · price: 200,000 sh · $26.49 a share
Held after: 1,654,597 sh
Stock: Roivant Sciences ROIV
Person: Eric VenkerPresident & Immunovant CEO
Trade date: 26/02/13
Filed: 26/02/18
Days to filing: 5 days

Sold 10.8% of holdings

Share of holding sold: 10.8%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 01/14~03/15

Eric Venker's recent trades

Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$1.5M
46,234 sh
$1.5M
Filed 06/26
Traded 06/24